Bank of New York Mellon’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-200,634
| Closed | -$9.43M | – | 4260 |
|
|
2025
Q2 | $9.43M | Buy |
200,634
+13,387
| +7% | +$596K | ﹤0.01% | 1935 |
|
|
2025
Q1 | $8.26M | Sell |
187,247
-8,695
| -4% | -$400K | ﹤0.01% | 1953 |
|
|
2024
Q4 | $7.08M | Sell |
195,942
-30,986
| -14% | -$1.08M | ﹤0.01% | 2111 |
|
|
2024
Q3 | $7.27M | Sell |
226,928
-72,033
| -24% | -$2.69M | ﹤0.01% | 2093 |
|
|
2024
Q2 | $11.3M | Buy |
298,961
+66,161
| +28% | +$2.78M | ﹤0.01% | 1898 |
|
|
2024
Q1 | $11.5M | Sell |
232,800
-8,322
| -3% | -$385K | ﹤0.01% | 1897 |
|
|
2023
Q4 | $8.8M | Buy |
241,122
+23,497
| +11% | +$613K | ﹤0.01% | 2046 |
|
|
2023
Q3 | $5.03M | Sell |
217,625
-2,678
| -1% | -$73.2K | ﹤0.01% | 2310 |
|
|
2023
Q2 | $5.78M | Buy |
220,303
+93,143
| +73% | +$2.45M | ﹤0.01% | 2241 |
|
|
2023
Q1 | $3.27M | Buy |
127,160
+1,242
| +1% | +$36.3K | ﹤0.01% | 2525 |
|
|
2022
Q4 | $3.28M | Sell |
125,918
-24,536
| -16% | -$605K | ﹤0.01% | 2577 |
|
|
2022
Q3 | $4.29M | Buy |
150,454
+22,733
| +18% | +$652K | ﹤0.01% | 2368 |
|
|
2022
Q2 | $3.15M | Buy |
127,721
+11,198
| +10% | +$410K | ﹤0.01% | 2579 |
|
|
2022
Q1 | $6.58M | Sell |
116,523
-602
| -0.5% | -$34.5K | ﹤0.01% | 2281 |
|
|
2021
Q4 | $7.26M | Buy |
117,125
+769
| +0.7% | +$50.9K | ﹤0.01% | 2269 |
|
|
2021
Q3 | $7.38M | Buy |
116,356
+7,360
| +7% | +$567K | ﹤0.01% | 2290 |
|
|
2021
Q2 | $8.98M | Buy |
108,996
+19,006
| +21% | +$1.44M | ﹤0.01% | 2205 |
|
|
2021
Q1 | $6.62M | Sell |
89,990
-2,102
| -2% | -$165K | ﹤0.01% | 2314 |
|
|
2020
Q4 | $6.68M | Buy |
92,092
+16,582
| +22% | +$1.07M | ﹤0.01% | 2217 |
|
|
2020
Q3 | $3.6M | Buy |
75,510
+530
| +0.7% | +$22.6K | ﹤0.01% | 2387 |
|
|
2020
Q2 | $3.15M | Buy |
74,980
+35,720
| +91% | +$1.27M | ﹤0.01% | 2442 |
|
|
2020
Q1 | $1.06M | Buy |
39,260
+13,179
| +51% | +$430K | ﹤0.01% | 2938 |
|
|
2019
Q4 | $1M | Buy |
+26,081
| New | +$610K | ﹤0.01% | 3245 |
|
Other funds holding SWTX
Bank of New York Mellon's SWTX Position: Q3 2025 in Review
Bank of New York Mellon sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 200,634 shares — an estimated $9.43M sold.
Bank of New York Mellon first reported a position in SWTX in Q4 2019 and held it in 23 quarters. The position peaked at $11.5M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Bank of New York Mellon reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Bank of New York Mellon sold 200,634 SpringWorks Therapeutics shares in Q3 2025, an estimated $9.43M.
- Bank of New York Mellon first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 23 quarters.
- Bank of New York Mellon's SpringWorks Therapeutics position peaked at $11.5M in Q1 2024.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Bank of New York Mellon's 13F filing for Q3 2025, filed 3 Nov 2025.